Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017)
Exelixis' (EXEL) quarterly Amortization of Deferred Charges came in at $93000.0 in Q2 2017, down 17.7% year-on-year from $113000.0 in Q2 2016, and up 4.49% quarter-over-quarter from $89000.0 in Q1 2017.
Exelixis (EXEL) Amortization of Deferred Charges (2015 - 2017) Analysis & Trends
Exelixis' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $93000.0 for Q2 2017.
- On a quarterly basis, Amortization of Deferred Charges fell 17.7% year-over-year to $93000.0 in Q2 2017; TTM through Jun 2018 was $93000.0, a 101.68% increase from a year earlier, with the FY2017 full-year figure at $182000.0, down 97.84% from the prior year.
- Amortization of Deferred Charges climbed to $93000.0 in Q2 2017 per EXEL's latest filing, from $89000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $4.8 million in Q2 2015 and bottomed at -$5.8 million in Q4 2016.
- The 3-year median for Amortization of Deferred Charges is $117000.0 (2016), against an average of $687125.0.
- Across the five-year window, Amortization of Deferred Charges tumbled 97.66% in 2016 and declined 17.7% in 2017, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $2.9 million in 2015, then plunged by 299.45% to -$5.8 million in 2016, then soared by 101.59% to $93000.0 in 2017.
- Per Business Quant, the three latest EXEL Amortization of Deferred Charges figures stand at $93000.0 (Q2 2017), $89000.0 (Q1 2017), and -$5.8 million (Q4 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Exelixis | 14.44 Bn | 13.66 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 93,000.00 |
| Jun 30, 2017 | 93,000.00 |
| Mar 31, 2017 | 89,000.00 |
| Mar 31, 2017 | 89,000.00 |
| Dec 30, 2016 | -5.84 Mn |
| Dec 30, 2016 | -5.84 Mn |
| Sep 30, 2016 | 121,000.00 |
| Sep 30, 2016 | 121,000.00 |
| Jun 30, 2016 | 113,000.00 |
| Jun 30, 2016 | 113,000.00 |
| Mar 31, 2016 | 3.16 Mn |
| Mar 31, 2016 | 3.16 Mn |
| Sep 30, 2015 | 2.93 Mn |
| Sep 30, 2015 | 2.93 Mn |
| Jun 30, 2015 | 4.83 Mn |
| Jun 30, 2015 | 4.83 Mn |